Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,143 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 232
Ph III recruiting: 18
Growth YoY: +4.2%
Industry share: 30%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 301–350 of 393 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00588913	Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases	completed	Phase 1 / Phase 2	20	Tokyo Women's Medical UniversityOTHER	1	Jul 10, 2013	clinicaltrials
NCT00003103	Chemotherapy in Treating Patients With Solid Tumors	completed	Phase 1 / Phase 2	57	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 3, 2013	clinicaltrials